Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2010-10-5
pubmed:abstractText
HER2/neu status of tumor cells at metastatic sites in patients with advanced disease may differ from that of the primary tumor. Assessing the presence of target antigens on circulating tumor cells (CTCs) might affect treatment choice.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1938-0666
pubmed:author
pubmed:issnType
Electronic
pubmed:day
1
pubmed:volume
10
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
392-7
pubmed:meshHeading
pubmed:year
2010
pubmed:articleTitle
Changes of HER2 status in circulating tumor cells compared with the primary tumor during treatment for advanced breast cancer.
pubmed:affiliation
Division of Medical Oncology, European Institute of Oncology, Milan, Italy. elisabetta.munzone@ieo.it
pubmed:publicationType
Journal Article